New EU project aims to advance pandemic preparedness

With viral disease emergence expected to accelerate, preparing for possible future pandemics is paramount.

Kronos Bio axes nearly one-fifth of staff to preserve cash for two cancer programs

Kronos Bio is downsizing its workforce by 19% as part of broader restructuring efforts meant to save cash, so that the company can continue work

November 4, 2023

Twice-Yearly Biologic Effective Against Nasal Polyps

SAN DIEGO — Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps

March 3, 2025

Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.